Articles by author - Radka Dolezalová

Fenofibrate and rosiglitazone improve quality of lipoproteins in patients with type 2 diabetes mellitus.

Vrablík M, Dobiásová M, Stulc T, Kasalová Z, Dolezalová R, Prázný M, Fait T, Ceska R.

Controlled Clinical Trial 2008; 29(1): 146-150 PubMed PMID: 18283261  Keywords:  Aged, Biomarkers:blood, Cardiovascular Diseases:blood, Cholesterol, LDL:blood, Diabetes Mellitus, Type 2:blood, Female, Fenofibrate:adverse effects, Humans, Lipoproteins:blood, Male, Middle Aged, Peroxisome Proliferator-Activated Receptors:agonists, Phosp.    Citation

BACKGROUND: Particle size distribution in both HDL and LDL is reflected in the fractional esterification rate of cholesterol by lecithin c.....

Read abstract  Full text PDF